Hoth Therapeutics, Inc. - COM NEW (HOTH)

CUSIP: 44148G204

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / COM NEW
Total 13F shares
366,257
Share change
+17,749
Total reported value
$322,270
Price per share
$0.88
Number of holders
11
Value change
+$9,339
Number of buys
7
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 44148G204?
CUSIP 44148G204 identifies HOTH - Hoth Therapeutics, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Hoth Therapeutics, Inc. - COM NEW (HOTH) as of Q3 2024

As of 30 Sep 2024, Hoth Therapeutics, Inc. - COM NEW (HOTH) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 366,257 shares. The largest 10 holders included HRT FINANCIAL LP, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, VANGUARD GROUP INC, Virtu Financial LLC, TWO SIGMA SECURITIES, LLC, MORGAN STANLEY, Tower Research Capital LLC (TRC), BANK OF AMERICA CORP /DE/, and OSAIC HOLDINGS, INC.. This page lists 11 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.